Page 2 - John Thero News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19 Recedes Expenses Managed in Q1 2021 to Minimize Operating Loss Despite Revenue Impact of COVID-19 and Other Factors Management to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2021 and provided an update on compan...

Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks Steve A. Cohen is the owner of Point72 Asset Management, one of the most successful hedge funds in the U.S. He started off his Wall Street career as a junior trader at Gruntal & Co., where he dealt with options arbitrage. Cohen started his first hedge fund known as S.A.C. Capital Advisors in 1992, enjoying some success which allowed him to own 8 percent of Major League Baseball team, the New York Mets. He has also been involved in philanthropic causes in which he contributed $715 million. Unfortunately, SAC Capital was allegedly involve...

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Amarin (NASDAQ:AMRN) were 10.4% lower as of 11:20 a.m. EDT on Tuesday. The decline came after the drugmaker announced that John Thero plans to retire as president and CEO effective Aug. 1. So what It's not unusual for changes at the CEO level to caus...

Author Bio Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles. What happened Amarin (NASDAQ:AMRN) enjoyed a 7.7% ride skyward on Monday. This was on the back of a regulatory document filed after market hours on Friday detailing some new incentives for top management. So what Amarin disclosed in the document ...

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug The drug is recommended for use in adult patients who are already receiving statin treatment The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Amarin’s fish oil-derived drug icosapent ethyl for the prevention of cardiovascular events in high-risk patients. The CHMP has adopted a positive opinion for marketing authorisation of the drug under the brand name Vazkepa in the EU. The committee has recommended use of the drug in adult patients already receiving ...